CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles
CVRx , Inc. (NASDAQ:CVRX), a medical device company with a market capitalization of $382 million specializing in the development and commercialization of the Barostim therapy for heart failure and ...
CureVac's SWOT analysis: mRNA pioneer's stock faces pivotal year in vaccine race
CureVac N.V. (NASDAQ:CVAC), a biopharmaceutical company specializing in mRNA-based therapies and vaccines with a market ...
Investing22d
Neurocrine Biosciences' SWOT analysis: stock outlook amid pipeline progress and market challenges
InvestingPro analysis indicates the stock is currently ... The decision to move directly to Phase 3 trials without additional Phase 2b studies could be seen as premature and risky.
Investing23d
Arcturus Therapeutics' SWOT analysis: mRNA innovator's stock faces pivotal year
According to InvestingPro analysis, the company's stock shows significant ... ARCT-032 for Cystic Fibrosis (CF): The LunairCF study (NCT06747858) involves 12 CF patients and focuses on adverse ...
Slate23d
Neko Case’s Memoir Is Haunting, Page-Turning, and Revelatory
The singer-songwriter Neko Case’s new memoir is a superhero origin story. But here, instead of an anonymous mugger gunning down the parents, sending pearls scattering over the pavement ...
Rolling Stone28d
Neko Case Never Wanted to Write a Tell-All. But Her New Memoir Is as Intense and Captivating as Her Songs
People always ask Neko Case how she writes her songs. She can’t explain it — some are “grim chores,” others seem “like they just fell out of a pocket of a coat I haven’t worn in a ...